SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-252189
Filing Date
2012-05-30
Accepted
2012-05-30 08:01:19
Documents
5
Period of Report
2012-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d360711d8k.htm 8-K 20364
2 FORM OF WARRANT d360711dex48.htm EX-4.8 85398
3 FORM OF SECURITIES PURCHASE AGREEMENT d360711dex1023.htm EX-10.23 299274
4 PRESS RELEASE d360711dex991.htm EX-99.1 7690
5 GRAPHIC g360711ex99_1pg01.jpg GRAPHIC 6944
  Complete submission text file 0001193125-12-252189.txt   423609
Mailing Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 12875718
SIC: 2834 Pharmaceutical Preparations